ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Cerminara, S.E.; Cvijetic, I.; Huber, S.; Müller, S.; Kostner, L.; Goessinger, E.V.; Narainsing, J.; Dutilh, G.; Heidemeyer, K.; Yawalkar, N.; Conrad, C.; Plaza, T.; Maul, J.T.; Cozzio, A.; Navarini, A.A.

doi:10.1111/jdv.20400

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Détails

Demande d'une copie

ID Serval

serval:BIB_2627DC6163D3

Type

Article: article d'un périodique ou d'un magazine.

Collection

Publications

Institution

UNIL/CHUV

Titre

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Périodique

Journal of the European Academy of Dermatology and Venereology

Auteur⸱e⸱s

Cerminara S.E., Cvijetic I., Huber S., Müller S., Kostner L., Goessinger E.V., Narainsing J., Dutilh G., Heidemeyer K., Yawalkar N., Conrad C., Plaza T., Maul J.T., Cozzio A., Navarini A.A.

ISSN

1468-3083 (Electronic)

ISSN-L

0926-9959

Statut éditorial

In Press

Peer-reviewed

Oui

Langue

anglais

Notes

Publication types: Letter
Publication Status: aheadofprint

OAI-PMH

oai:serval.unil.ch:BIB_2627DC6163D3

DOI

10.1111/jdv.20400

Pubmed

39445679

Web of science

001341011000001

Open Access

Oui

Création de la notice

28/10/2024 15:00

Dernière modification de la notice

22/11/2024 17:55

Données d'usage

SERVAL

serveur académique lausannois

ApreScalp: A Phase 4 multicentre, randomized, placebo-controlled study evaluating the effect of apremilast on pruritus and quality of life of patients with moderate-to-severe scalp psoriasis.

Détails